𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Denosumab for the Reduction of Bone Loss in Postmenopausal Osteoporosis: A Review

✍ Scribed by Mary Barna Bridgeman; Rolee Pathak

Book ID
113544510
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
744 KB
Volume
33
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of denosumab on bone turnover ma
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
✍ Richard Eastell; Claus Christiansen; Andreas Grauer; Stepan Kutilek; Cesar Liban πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 272 KB πŸ‘ 1 views

## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumab‐treat